用奈他地尔治疗的水肿性角膜中的网状上皮水肿 - Suppr

Suppr

超能文献

Reticular Epithelial Edema in Edematous Corneas Treated with Netarsudil.

作者信息

Fernandez Mark M

机构信息

Virginia Ophthalmology Associates, Norfolk, Virginia.

出版信息

Ophthalmology. 2018 Nov;125(11):1709. doi: 10.1016/j.ophtha.2018.08.004.

DOI:10.1016/j.ophtha.2018.08.004

PMID:30318038

Abstract

摘要

相似文献

Reticular Epithelial Edema in Edematous Corneas Treated with Netarsudil.

Ophthalmology. 2018 Nov;125(11):1709. doi: 10.1016/j.ophtha.2018.08.004.

A Patient With Glaucoma With Corneal Edema.

JAMA Ophthalmol. 2020 Aug 1;138(8):917-918. doi: 10.1001/jamaophthalmol.2020.1023.

Netarsudil-Associated Reticular Corneal Epithelial Edema with Raised Intraocular Pressure.

Ophthalmol Glaucoma. 2019 May-Jun;2(3):166. doi: 10.1016/j.ogla.2019.01.001.

Honeycomb Epithelial Edema Associated With Rho Kinase Inhibition: A Case Series and Review of the Literature.

Cornea. 2022 Feb 1;41(2):243-248. doi: 10.1097/ICO.0000000000002694.

Reticular Bullous Epithelial Edema in Corneas Treated with Netarsudil: A Case Series.

Am J Ophthalmol. 2020 Sep;217:20-26. doi: 10.1016/j.ajo.2020.04.002. Epub 2020 Apr 11.

Reticular Epithelial Edema: An Uncommon Side Effect of ROCK/NET Inhibitor Netarsudil.

J Glaucoma. 2020 Nov;29(11):e124-e126. doi: 10.1097/IJG.0000000000001636.

Reticular epithelial corneal oedema secondary to topical netarsudil drops.

Natl Med J India. 2023 Jul-Aug;36(4):274-275. doi: 10.25259/NMJI_675_22.

Transient Reticular Cystic Corneal Epithelial Edema With Topical Netarsudil: A Case Series and Review.

Cornea. 2021 Aug 1;40(8):1048-1054. doi: 10.1097/ICO.0000000000002621.

Reticular Corneal Edema or Corneal Honeycombing in Eyes Treated With Netarsudil: A Case Series.

J Glaucoma. 2020 Jul;29(7):607-610. doi: 10.1097/IJG.0000000000001516.

Case Series: Novel Utilization of Rho-Kinase Inhibitor for the Treatment of Corneal Edema.

Cornea. 2021 Jan;40(1):116-120. doi: 10.1097/ICO.0000000000002421.

引用本文的文献

A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS).

BMC Pharmacol Toxicol. 2025 Apr 21;26(1):88. doi: 10.1186/s40360-025-00927-x.

Ocular effects of Rho kinase (ROCK) inhibition: a systematic review.

Eye (Lond). 2024 Dec;38(18):3418-3428. doi: 10.1038/s41433-024-03342-4. Epub 2024 Sep 16.

Topical netarsudil for the treatment of primary corneal endothelial degeneration in dogs.

Sci Rep. 2024 Mar 14;14(1):6238. doi: 10.1038/s41598-024-56084-4.

Phase 2, Randomized, Open-Label Parallel-Group Study of Two Dosing Regimens of Netarsudil for the Treatment of Corneal Edema Due to Fuchs Corneal Dystrophy.

J Ocul Pharmacol Ther. 2022 Dec;38(10):657-663. doi: 10.1089/jop.2022.0069. Epub 2022 Nov 3.

Reticular epithelial edema after penetrating keratoplasty in a patient taking netarsudil.

Digit J Ophthalmol. 2022 Jun 27;28(8):34-37. doi: 10.5693/djo.02.2022.02.002. eCollection 2022.

"Rapid and reversible alteration in corneal contour and power associated with Netarsudil/Latanoprost".

Am J Ophthalmol Case Rep. 2022 Mar 25;26:101501. doi: 10.1016/j.ajoc.2022.101501. eCollection 2022 Jun.

Reticular epithelial corneal edema as a novel side-effect of Rho Kinase Inhibitors: An Indian scenario.

Indian J Ophthalmol. 2022 Apr;70(4):1163-1170. doi: 10.4103/ijo.IJO_2865_21.

Netarsudil-associated reticular corneal epithelial edema.

Am J Ophthalmol Case Rep. 2022 Jan 20;25:101287. doi: 10.1016/j.ajoc.2022.101287. eCollection 2022 Mar.

Rhopressa-induced corneal edema: a case report.

J Med Case Rep. 2021 Apr 2;15(1):182. doi: 10.1186/s13256-021-02665-0.

A Case Report Illustrating the Postoperative Course of Descemetorhexis without Endothelial Keratoplasty with Topical Netarsudil Therapy.

Case Rep Ophthalmol Med. 2019 Oct 13;2019:6139026. doi: 10.1155/2019/6139026. eCollection 2019.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验